參考文獻/References:
[1] 王燕逍翔,白建軍,宇傳華.基于全球視角的中國心血管病疾病負擔現(xiàn)狀及趨勢[J].公共衛(wèi)生與預防醫(yī)學,2021,32(06):6-11.
[2] Chen M S,John J M,Chew D P,et al.Bare metal stent restenosis is not a benign clinical entity[J].Am Heart J,2006,151(6):1260-1264.
[3] Carlsson L, Nyström L E, Sundkvist I, et al.Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells[J].J Mol Biol,1977,115(3):465-483.
[4] Caglayan E, Romeo G R, Kappert K,et al.Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells[J].PloS one,2010,5(10):e13608.
[5] 黎嘉雯,袁德山,蘇淑紅.血小板反應性對使用比伐盧定抗凝的擇期經(jīng)皮冠狀動脈介入治療患者臨床事件的影響[J].中華心血管病雜志,2021,49(08):783-789.
[6] Giulio R,Romeo,Andrius,et al.Oxysterol and diabetes activate STAT3 and control endothelial expression of profilin-1 via OSBP1[J].The Journal of biological chemistry,2008,283(15):9595-9605.